Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Treatment Strategy for Patients With Multiple Recurrent Clostridioides Difficile Infection With Bezlotoxumab as First Option

NCT05077085 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05077085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05077085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Treatment Strategy for Patients With Multiple Recurrent Clostridioides Difficile Infection With Bezlotoxumab as First Option
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2022
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

clostridioides difficile, clostridium infections, enterocolitis, pseudomembranous